BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Diagnosis
4 results:

  • 1. Metastatic malignant melanoma mimicking a salivary gland basaloid neoplasm after treatment with nivolumab.
    Lajara S; Landau M
    Diagn Cytopathol; 2021 Sep; 49(9):E370-E373. PubMed ID: 34174024
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trial.
    Janda M; Horsham C; Vagenas D; Loescher LJ; Gillespie N; Koh U; Curiel-Lewandrowski C; Hofmann-Wellenhof R; Halpern A; Whiteman DC; Whitty JA; Smithers BM; Soyer HP
    Lancet Digit Health; 2020 Mar; 2(3):e129-e137. PubMed ID: 33334577
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Transcriptome profiling identifies hmga2 as a biomarker of melanoma progression and prognosis.
    Raskin L; Fullen DR; Giordano TJ; Thomas DG; Frohm ML; Cha KB; Ahn J; Mukherjee B; Johnson TM; Gruber SB
    J Invest Dermatol; 2013 Nov; 133(11):2585-2592. PubMed ID: 23633021
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Differential expression of HMGA1 and hmga2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
    Li N; McNiff J; Hui P; Manfioletti G; Tallini G
    Am J Dermatopathol; 2004 Aug; 26(4):267-72. PubMed ID: 15249855
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.